Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.

MLA

Dahmen, Safia, et al. “Imipenem Resistance in Klebsiella Pneumoniae Is Associated to the Combination of Plasmid-Mediated CMY-4 AmpC β-Lactamase and Loss of an Outer Membrane Protein.” Microbial Drug Resistance (Larchmont, N.Y.), vol. 18, no. 5, Oct. 2012, pp. 479–83. EBSCOhost, https://doi.org/10.1089/mdr.2011.0214.

APA

Dahmen, S., Mansour, W., Charfi, K., Boujaafar, N., Arlet, G., & Bouallègue, O. (2012). Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein. Microbial Drug Resistance (Larchmont, N.Y.), 18(5), 479–483. https://doi.org/10.1089/mdr.2011.0214

Chicago

Dahmen, Safia, Wejdène Mansour, Karama Charfi, Noureddine Boujaafar, Guillaume Arlet, and Olfa Bouallègue. 2012. “Imipenem Resistance in Klebsiella Pneumoniae Is Associated to the Combination of Plasmid-Mediated CMY-4 AmpC β-Lactamase and Loss of an Outer Membrane Protein.” Microbial Drug Resistance (Larchmont, N.Y.) 18 (5): 479–83. doi:10.1089/mdr.2011.0214.